About The Study: Statin use for primary prevention of atherosclerotic cardiovascular disease (ASCVD) was low among all race and ethnicity groups regardless of ASCVD risk, with the lowest use occurring among Black and Hispanic adults in this study of survey data representing 39.4 million adults. Improvements in access to care may promote equitable use of primary prevention statins in Black and Hispanic adults.
Authors: Joshua A. Jacobs, Pharm.D., of the Spencer Fox Eccles University of Utah School of Medicine in Salt Lake City, and Ambarish Pandey, M.D., of the University of Texas Southwestern Medical Center in Dallas, are the corresponding authors.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2023.0228?guestAccessKey=d919418f-504f-4364-afe6-163fad941dda&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032223